Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma

Bone Marrow Transplantation

Volumn 49, Issue 7, 2014, Pages 907-912

  Greenfield, D M ^a   Boland, E ^b   Ezaydi, Y ^c   Ross, R J M ^b   Ahmedzai, S H ^b   Snowden, J A ^c  

^a WESTON PARK HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; CYCLOPHOSPHAMIDE; MELPHALAN; STEROID; ZOLEDRONIC ACID;

ADRENAL CORTEX INSUFFICIENCY; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BODY COMPOSITION; BODY MASS; BONE DENSITY; BONE TURNOVER; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CAUCASIAN; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMORBIDITY; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DONOR LYMPHOCYTE INFUSION; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOCRINE DISEASE; FEMALE; FOLIC ACID DEFICIENCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORMONE SUBSTITUTION; HUMAN; HYPERPROLACTINEMIA; HYPERTENSION; HYPOGONADISM; HYPOTHYROIDISM; LONG TERM SURVIVAL; MALE; MALE INFERTILITY; METABOLIC DISORDER; MULTIPLE MYELOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; OBESITY; OSTEOLYSIS; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; SARCOPENIC OBESITY; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; CROSS-SECTIONAL STUDY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BODY COMPOSITION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NUTRITIONAL STATUS;

EID: 84927798367     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.63     Document Type: Article

References (27)

1. Bird JM, Owen RG, DSa S, Snowden JA, Pratt G, Ashcroft J et al. Guidelines for the diagnosis and management of multiple myeloma 2011. Br J Haematol 2011; 154: 32-75.
2. Snowden JA, Ahmedzai SH, Ashcroft J, DSa S, Littlewood T, Low E et al. Guidelines for supportive care in multiple myeloma 2011. Br J Haematology 2011; 154: 76-103.
3. Klepin HD, Hurd DD. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions? Bone Marrow Transplant 2006; 38: 585-592.
4. National Institutes of Health. Late effects definition. In National Cancer Institute Dictionary of Cancer Terms http://www.cancer.gov/dictionary? cdrid=390292Accessed30January2014.
5. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666-3672.
6. Stewart J, Turner KJ. Inhibin B as a potential biomarker of testicular toxicity. Cancer Biomark 2005; 1: 75-91.
7. van Beek RD, Smit M, van den Heuvel-Eibrink MM, de Jong FH, Hakvoort-Cammel FG, van den Bos C et al. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkins lymphoma with chemotherapy during childhood. Hum Reprod 2007; 22: 3215-3222.
8. Balcerek M, Reinmuth S, Hohmann C, Keil T, Borgmann-Staudt A. Suspected infertility after treatment for leukemia and solid tumors in childhood and adolescence. Dtsch Arzteb Int 2012; 109: 126-131.
9. Glover SJ, Garnero P, Naylor K, Rogers A, Eastell R. Establishing a reference range for bone turnover markers in young, healthy women. Bone 2008; 42: 623-630.
10. Rogers A, Glover SJ, Eastell R. A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy. Bone 2009; 45: 1044-1052.
11. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med 2001; 137: 231-243.
12. Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M et al. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 2003; 51: 1602-1609.
13. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137-1141.
14. Eiser C, Absolom K, Greenfield D, Snowden J, Coleman R, Hancock B et al. Followup care for young adult survivors of cancer: lessons from pediatrics. J Cancer Surviv 2007; 1: 75-86.
15. Demark-Wahnefried W, Pinto BM, Gritz ER. Promoting health and physical function among cancer survivors: potential for prevention and questions that remain. J Clin Oncol 2006; 24: 5125-5131.
16. Baker KS, Ness KK, Steinberger J, Carter A, Francisco L, Burns LJ et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic celltransplantation: a report from the bone marrow transplantation survivor study. Blood 2007; 109: 1765-1772.
17. Greenfield DM, Absolom K, Eiser C, Walters SJ, Michel G, Hancock BW et al. Followup care for cancer survivors: the views of clinicians. Br J Cancer 2009; 101: 568-574.
18. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C et al. Recommended screening and preventative practices for long-term survivors after haematopoietic cell transplantation. Bone Marrow Transplant 2012; 47: 337-341.
19. Badros AZ, Siegel E, Bodenner D, Zangari M, Zeldis J, Barlogie B et al. Hypothyroidism in patients with multiple myeloma following treatment with thalidomide. Am J Med 2002; 112: 412-413.
20. Vuong C, Van Uum SH, ODell LE, Lutfy K, Friedman TC. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocrine Rev 2010; 31: 98-132.
21. Greenfield DM, Walters SJ, Coleman RE, Hancock BW, Eastell R, Davies HA et al. Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study. J Clin Endocrinol Metab 2007; 92: 3476-3482.
22. Greenfield DM, Walters SJ, Coleman RE, Hancock BW, Snowden JA, Shalet SM et al. Health related quality of life, self-esteem, fatigue and sexual function in young men after cancer: a controlled cross-sectional study. Cancer 2010; 116: 1592-1601.
23. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412-423.
24. Baz R, Alemany C, Green R, Hussein MA. Prevalence of vitamin B12 deficiency in patients with plasma cell dyscrasias: a retrospective review. Cancer 2004; 101: 790-795.
25. Pearce SH, Cheetham TD. Diagnosis and management of vitamin D deficiency. Br Med J 2010; 340: b5664.
26. Badros A, Goloubeva O, Terpos E, Milliron T, Baer MR, Streeten E. Prevalence and significance of vitamin D deficiency in multiple myeloma patients. Br J Haematol 2008; 142: 492-494.
27. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA et al. A pooled analysis of vitamin D dose requirements for fracture prevention. New Engl J Med 2012; 367: 40-49.